share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 22 00:41
Summary by Futu AI
Vertex Pharmaceuticals Inc. officer Stuart A. Arbuckle is set to sell 3,603 shares of common stock on 02/21/2024, as per the latest filing. The shares, valued at approximately $1,519,637.31, were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Arbuckle, who has sold 17,702 shares over the past three months, totaling roughly $7,259,002.96 in gross proceeds.
Vertex Pharmaceuticals Inc. officer Stuart A. Arbuckle is set to sell 3,603 shares of common stock on 02/21/2024, as per the latest filing. The shares, valued at approximately $1,519,637.31, were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Arbuckle, who has sold 17,702 shares over the past three months, totaling roughly $7,259,002.96 in gross proceeds.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.